P-212 Factors affecting median PFS in patients with advanced, non-resectable well differentiated pancreatic neuroendocrine tumors treated initially with octreotide LAR - real world data
Kolasinska-CwikÅa, A., ÄwikÅa, J., Bednarczuk, T., Osoweicka, K., SkowroÅska, A., PaÅucki, J., Roszkowska-Purska, K., Samsel, R., Cichocki, A.Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.04.294
Date:
July, 2020
File:
PDF, 83 KB
2020